It’s just one of the far-reaching, trickle-down effects of President Donald Trump’s sweeping executive actions that threaten to slow or halt health and science research in the United States ...

The survey, conducted from December 1-7, 2024, showed that incumbent 2nd District Representative and gubernatorial candidate L-ray Villafuerte trailed in the polls among CSPC students’ governor ...

Jan. 27, 2025 — A large proportion of babies born very early need intensive care, which can be painful. But the healthcare system fails to provide pain relief to the full extent. This is shown ...

Two decades after “The Republican War on Science” was published ... NBC News reported: The National Institutes of Health announced Friday that the agency is making cuts to grants that support ...

The health sciences study all aspects of health, disease and healthcare. This field of study aims to develop knowledge, interventions and technology for use in healthcare to improve the treatment ...

Jan. 30, 2025 — A green alga that grows in lakes and rivers could be the next 'superfood' -- helping scientists to tackle global food security challenges while promoting environmental ...

Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically modified to carry a human gene—for studying hepatitis B virus.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BlackRock Health Sciences Opps Inv A’s Process Pillar rating is Average, but a strong management team still helps this strategy retain its Morningstar Medalist Rating of Bronze. Our research ...

AstraZeneca has joined the ranks of pharma companies seeking to bring drugs targeting lipoprotein(a) to market, paying $100 million upfront for rights to a drug developed by CSPC Pharmaceutical.

A class action lawsuit was filed against Cassava Sciences Inc. (SAVA) by Levi & Korsinsky on December 12, 2024. The plaintiffs (shareholders) alleged that they bought SAVA stock at artificially ...

The study characterized plasma cell-free DNA (cfDNA) variants of tumor, CH or germline origin in 16,812 patients with advanced cancer using Caris Assure, which sequences both the plasma and buffy ...